CN114748396A - Soothing and moisturizing composition suitable for desert muscles and preparation method and application thereof - Google Patents
Soothing and moisturizing composition suitable for desert muscles and preparation method and application thereof Download PDFInfo
- Publication number
- CN114748396A CN114748396A CN202210600680.5A CN202210600680A CN114748396A CN 114748396 A CN114748396 A CN 114748396A CN 202210600680 A CN202210600680 A CN 202210600680A CN 114748396 A CN114748396 A CN 114748396A
- Authority
- CN
- China
- Prior art keywords
- soothing
- percent
- phase
- skin
- moisturizing composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 72
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 210000003205 muscle Anatomy 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 239000006071 cream Substances 0.000 claims abstract description 43
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 21
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 21
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 claims abstract description 18
- PUGFCQQOYJMKOO-UHFFFAOYSA-N n-(3-hexadecoxy-2-hydroxypropyl)-n-(2-hydroxyethyl)hexadecanamide Chemical compound CCCCCCCCCCCCCCCCOCC(O)CN(CCO)C(=O)CCCCCCCCCCCCCCC PUGFCQQOYJMKOO-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 238000004519 manufacturing process Methods 0.000 claims abstract description 11
- 239000010404 Scutellaria baicalensis extract Substances 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000000284 extract Substances 0.000 claims description 20
- 239000003974 emollient agent Substances 0.000 claims description 17
- 239000003995 emulsifying agent Substances 0.000 claims description 17
- 239000002562 thickening agent Substances 0.000 claims description 17
- 239000003963 antioxidant agent Substances 0.000 claims description 16
- 230000003078 antioxidant effect Effects 0.000 claims description 16
- 239000002738 chelating agent Substances 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 15
- 150000005846 sugar alcohols Polymers 0.000 claims description 14
- 239000008367 deionised water Substances 0.000 claims description 13
- 229910021641 deionized water Inorganic materials 0.000 claims description 13
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 239000003755 preservative agent Substances 0.000 claims description 10
- 230000002335 preservative effect Effects 0.000 claims description 10
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 8
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 230000003750 conditioning effect Effects 0.000 claims description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000002537 cosmetic Substances 0.000 claims description 5
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 4
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 claims description 4
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 claims description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 4
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 4
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 4
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 4
- 229960000458 allantoin Drugs 0.000 claims description 4
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 claims description 4
- 230000002421 anti-septic effect Effects 0.000 claims description 4
- 229920006037 cross link polymer Polymers 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 229940100524 ethylhexylglycerin Drugs 0.000 claims description 4
- 229940100554 isononyl isononanoate Drugs 0.000 claims description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 4
- 229960005323 phenoxyethanol Drugs 0.000 claims description 4
- 229940057910 shea butter Drugs 0.000 claims description 4
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 4
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 4
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 4
- XYTHHAXRVHHXKO-JIUYZRCGSA-N 18-[(2r,3s,4r,5r)-4,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxyoctadecanoic acid;ethanol Chemical compound CCO.COC1O[C@H](CO)[C@@H](OCCCCCCCCCCCCCCCCCC(O)=O)[C@H](O)[C@H]1O XYTHHAXRVHHXKO-JIUYZRCGSA-N 0.000 claims description 3
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 claims description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical group CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 3
- -1 PEG-100 stearate Chemical compound 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 3
- 229920005862 polyol Polymers 0.000 claims description 3
- 150000003077 polyols Chemical class 0.000 claims description 3
- 229940042585 tocopherol acetate Drugs 0.000 claims description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 2
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- 241001530056 Athelia rolfsii Species 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 2
- 241000195480 Fucus Species 0.000 claims description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
- 239000004472 Lysine Substances 0.000 claims description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
- 240000007817 Olea europaea Species 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 229960001631 carbomer Drugs 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 claims description 2
- 229930182478 glucoside Natural products 0.000 claims description 2
- 150000008131 glucosides Chemical class 0.000 claims description 2
- 229940075529 glyceryl stearate Drugs 0.000 claims description 2
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 229940049964 oleate Drugs 0.000 claims description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 2
- 229940101267 panthenol Drugs 0.000 claims description 2
- 239000011619 pantothenol Substances 0.000 claims description 2
- 235000020957 pantothenol Nutrition 0.000 claims description 2
- 229940100460 peg-100 stearate Drugs 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 239000001509 sodium citrate Substances 0.000 claims description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 2
- 239000000230 xanthan gum Substances 0.000 claims description 2
- 229920001285 xanthan gum Polymers 0.000 claims description 2
- 235000010493 xanthan gum Nutrition 0.000 claims description 2
- 229940082509 xanthan gum Drugs 0.000 claims description 2
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical group CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 24
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 47
- 238000012360 testing method Methods 0.000 description 33
- 230000000052 comparative effect Effects 0.000 description 20
- 229940106189 ceramide Drugs 0.000 description 14
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 13
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 13
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 13
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 13
- 241000519987 Scutellaria alpina Species 0.000 description 12
- 238000013329 compounding Methods 0.000 description 10
- 150000003278 haem Chemical class 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 230000008591 skin barrier function Effects 0.000 description 7
- 230000000638 stimulation Effects 0.000 description 5
- 206010013786 Dry skin Diseases 0.000 description 4
- 230000037336 dry skin Effects 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 231100000430 skin reaction Toxicity 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical group [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- SUHOOTKUPISOBE-UHFFFAOYSA-N O-phosphoethanolamine Chemical compound NCCOP(O)(O)=O SUHOOTKUPISOBE-UHFFFAOYSA-N 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 239000007933 dermal patch Substances 0.000 description 2
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- NNRXCKZMQLFUPL-WBMZRJHASA-N (3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;(2r,3 Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O.O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 NNRXCKZMQLFUPL-WBMZRJHASA-N 0.000 description 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Natural products O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- KZTJQXAANJHSCE-OIDHKYIRSA-N N-octodecanoylsphinganine Chemical class CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC KZTJQXAANJHSCE-OIDHKYIRSA-N 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940098008 erythrocin Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000013022 formulation composition Substances 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000001821 langerhans cell Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- YHHSONZFOIEMCP-UHFFFAOYSA-O phosphocholine Chemical compound C[N+](C)(C)CCOP(O)(O)=O YHHSONZFOIEMCP-UHFFFAOYSA-O 0.000 description 1
- 229950004354 phosphorylcholine Drugs 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000009044 synergistic interaction Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a soothing and moisturizing composition suitable for desert muscles and a preparation method and application thereof, wherein the soothing and moisturizing composition comprises the following raw materials in percentage by weight: 0.1 to 0.5 percent of ceramide III, 1 to 7 percent of cetyl-PG hydroxyethyl palmitamide, 0.5 to 3 percent of scutellaria baicalensis extract and 0.02 to 0.7 percent of beta-glucan. The soothing and moisturizing composition provided by the invention is used for preparing soothing and moisturizing cream with good soothing, moisturizing and repairing effects. In addition, the preparation method disclosed by the invention is simple to operate, high in production efficiency and low in production cost, and can be used for large-scale production.
Description
Technical Field
The invention relates to the technical field of cosmetics, in particular to a soothing and moisturizing composition suitable for desert muscles and a preparation method and application thereof.
Background
Desert skin, as the name implies, is very dry, as in desert, even dry lines. The desert skin and the dry skin are not the same thing, the severity of water shortage of the dry skin is lower compared with the desert skin, the desert skin is very sensitive compared with the common dry skin, the common dry skin can be relieved by timely water replenishing and moisture retention, and the treatment of the desert skin generally needs to persist in water replenishing for a long time and simultaneously needs to relieve and repair the damaged skin barrier.
At present, products aiming at desert skin are relatively few in the market, so that the development of a product suitable for desert skin, which has a good soothing and moisturizing effect and can repair skin barriers, is very necessary.
Disclosure of Invention
Aiming at the defects in the prior art, the invention aims to provide a soothing and moisturizing composition suitable for desert muscles, a preparation method and application thereof, solves the problems of sensitive desert muscle dryness and skin barrier damage in the prior art, and is simple to operate, high in production efficiency, low in production cost and applicable to large-scale production.
In order to achieve the purpose, the invention adopts the following technical scheme:
in a first aspect, the invention provides a soothing and moisturizing composition suitable for desert muscles, which comprises the following raw materials in percentage by weight:
in some embodiments, the scutellaria baicalensis extract is a scutellaria alpina flower/leaf/stem extract, which is an extract obtained by extracting the flowers, leaves and stems of scutellaria alpina together.
In some embodiments, the soothing moisturizing composition further comprises a polyol, a chelating agent, a thickener, a skin conditioner, deionized water, an emulsifier, an emollient, an antioxidant, a PH adjuster, and a preservative.
In some technical schemes, the soothing and moisturizing composition is composed of the following raw materials in percentage by weight:
phase A: beta-glucan 0.02-0.7%, polyhydric alcohol 2-10%, chelating agent 0.01-0.5%, thickening agent 0.01-5%, skin conditioner 0.01-5%, and deionized water to make up to 100%;
phase B: 0.1 to 0.5 percent of ceramide III, 1 to 7 percent of cetyl-PG hydroxyethyl palmitamide, 0.5 to 5 percent of emulsifier, 1 to 10.5 percent of emollient and 0.01 to 1 percent of antioxidant;
and C phase: 0.5 to 3 percent of scutellaria baicalensis extract, 0.01 to 2 percent of PH regulator and 0.01 to 2 percent of preservative.
As a preferred technical scheme, the soothing and moisturizing composition is prepared from the following raw materials in percentage by weight:
phase A: beta-glucan 0.2%, polyhydric alcohol 2.5%, chelating agent 0.05%, thickening agent 0.4%, skin conditioning agent 0.17%, and deionized water to make up to 100%;
phase B: 0.5% of ceramide III, 5% of cetyl-PG hydroxyethyl palmitamide, 1.7% of emulsifier, 10.5% of emollient and 0.5% of antioxidant;
and C phase: 2.5 percent of scutellaria baicalensis extract, 0.2 percent of PH regulator and 0.55 percent of preservative.
In some embodiments, the polyol is at least one of glycerol, panthenol, propylene glycol, butylene glycol, and hexylene glycol.
As a preferable technical scheme, the polyalcohol is compounded by hexanediol and glycerol.
In some embodiments, the chelating agent is disodium EDTA.
In some embodiments, the preservative is at least one of phenoxyethanol, methylparaben, and ethylhexyl glycerin.
As a preferable technical scheme, the preservative is prepared by compounding phenoxyethanol and ethylhexyl glycerin.
In some technical schemes, the thickening agent is at least one of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, carbomer, hydroxyethyl cellulose, hydroxyethyl acrylate, sodium acryloyldimethyl taurate copolymer and xanthan gum.
As a preferable technical scheme, the thickening agent is acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer.
In some embodiments, the emulsifier is at least one of cetearyl glucoside, methylgluco sesquistearate, PEG-20 methylgluco sesquistearate, cetearyl olive oleate, PEG-100 stearate, glyceryl stearate.
As a preferable technical scheme, the emulsifier is compounded by adopting methyl glucose sesquistearate and PEG-20 methyl glucose sesquistearate.
In some embodiments, the antioxidant is tocopherol acetate.
In some embodiments, the emollient is at least one of isononyl isononanoate, caprylic capric triglyceride, hydrogenated polyisobutene, shea butter, dioctyl carbonate.
As a preferable technical scheme, the emollient is prepared by compounding isononyl isononanoate, caprylic capric triglyceride and shea butter.
In some embodiments, the skin conditioning agent is at least one of allantoin, sodium hyaluronate, hydrolyzed collagen, hydrolyzed sclerotium rolfsii gum, fucus extract, and arginine/lysine polypeptide.
As a preferable technical scheme, the skin conditioner is prepared by compounding allantoin and sodium hyaluronate.
In some embodiments, the PH adjusting agent is at least one of triethanolamine, aminomethyl propanol, potassium hydroxide, sodium hydroxide, citric acid, and sodium citrate.
According to a preferable technical scheme, the PH regulator is aminomethyl propanol.
In a second aspect, the present invention provides the use of said soothing and moisturizing composition in cosmetics suitable for desert muscles.
In some technical schemes, the cosmetic is any one of soothing moisturizing lotion, soothing moisturizing cream and soothing moisturizing cream.
In a third aspect, the invention provides a preparation method of the soothing and moisturizing composition as a soothing and moisturizing cream, which comprises the following steps:
(1) stirring the beta-glucan of the phase A, the polyalcohol, the chelating agent, the thickening agent and the skin conditioner by using part of deionized water until the beta-glucan, the polyalcohol, the chelating agent, the thickening agent and the skin conditioner are completely dissolved, heating to 80-85 ℃, and preserving heat;
(2) stirring the ceramide III, the cetyl-PG hydroxyethyl palmitamide, the emulsifier, the emollient and the antioxidant of the phase B with the rest deionized water until the ceramide III, the cetyl-PG hydroxyethyl palmitamide, the emulsifier, the emollient and the antioxidant are completely dissolved, heating to 80-85 ℃, and keeping the temperature;
(3) adding the phase B into the phase A raw material, and homogenizing at constant temperature for 3-5 minutes;
(4) cooling to 45 deg.C under stirring, adding Scutellariae radix extract of phase C, pH regulator and antiseptic, and stirring;
(5) stirring and cooling to below 38 ℃, and filtering out impurities to obtain the finished product.
Ceramide III: ceramide (Ceramide) is a kind of phospholipid with Ceramide as a skeleton, mainly comprising Ceramide phosphorylcholine and Ceramide phosphorylethanolamine, the phospholipid is a main component of a cell membrane, 40-50% of sebum in a horny layer is composed of Ceramide, and the Ceramide is a main part of an intercellular matrix and plays an important role in keeping the moisture balance of the horny layer. There are roughly 6 types of ceramides on the market, among which ceramide type iii rapidly and effectively penetrates into the intercellular substance, maintains skin elasticity and moisture, restores and reestablishes cell adhesiveness, rapidly restores dry and damaged skin, and is particularly desirable for sensitive skin.
cetyl-PG hydroxyethylpalmitamide is an analogue of ceramide NS/ceramide NG which enhances epidermal cohesion, repairs the skin barrier, and improves the skin's ability to retain moisture.
The beta-glucan can promote the proliferation of Langerhans cells so as to enhance the immunocompetence of the skin, has obvious anti-inflammatory and anti-allergic activities, has a film-forming property, and can help the skin to keep moisture.
The extract of the flowers, leaves and stems of the scutellaria alpina has obvious biological activity, has the functions of bacteriostasis, anti-inflammation and anti-allergic reaction, has the function of promoting the generation of ceramide, can improve the sebum composition, enables the skin to have the softness, can calm the skin and has certain red fading effect.
Compared with the prior art, the invention provides a novel anti-counterfeiting method, which has the following beneficial effects:
the soothing and moisturizing composition provided by the invention is used for preparing the soothing and moisturizing cream and has good soothing, moisturizing and repairing effects. Specifically, (1) the result of a skin patch test of a human body shows that the soothing and moisturizing cream does not have adverse reaction on the skin, and is safe and non-irritant. (2) From the moisturizing test results, the soothing moisturizing cream improves the moisture content of the skin and has better moisturizing effect due to the complex use of beta-glucan, the scutellaria alpina flower/leaf/stem extract, ceramide III and cetyl-PG hydroxyethyl palmitoyl. (3) According to the repairing effect test result, the soothing repairing cream prepared by compounding beta-glucan, the scutellaria alpina flower/leaf/stem extract, the ceramide III and the cetyl-PG hydroxyethyl palmitoyl can be synergistically enhanced, so that the effect of reducing the heme EI value of the soothing moisturizing cream is improved on one hand, and the soothing moisturizing cream has the effect of relieving SDS stimulation; on the other hand, the effect of the soothing moisturizing cream on reducing the percutaneous water loss is improved, and the soothing moisturizing cream prepared by the invention has the effect of repairing the skin barrier.
In addition, the preparation method provided by the invention is simple to operate, high in production efficiency and low in production cost, and can be used for large-scale production.
Detailed Description
The technical solutions of the present invention will be described clearly and completely by the detailed embodiments, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The present invention is further described below by way of examples 1 to 5.
Embodiments 1 to 5 respectively provide a soothing and moisturizing composition, which is a soothing and moisturizing cream, and comprises the following raw materials:
phase A: beta-glucan, polyalcohol, a chelating agent, a thickening agent, a skin conditioning agent and deionized water;
phase B: ceramide III, cetyl-PG hydroxyethyl palmitamide, emulsifier, emollient, antioxidant;
and C phase: scutellariae radix extract, pH regulator, and antiseptic.
Wherein the Scutellariae radix extract is obtained by extracting flos Scutellariae, folium Scutellariae and stems of Scutellaria alpina, and is purchased from Dismann. The polyalcohol is compounded by hexanediol and glycerol. The chelating agent is disodium EDTA. The thickening agent is acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer. The skin conditioner is prepared by compounding allantoin and sodium hyaluronate. The emulsifier is compounded with methyl glucose sesquistearate and PEG-20 methyl glucose sesquistearate. The emollient is prepared by compounding isononyl isononanoate, caprylic capric triglyceride and shea butter. The antioxidant is tocopherol acetate. The PH regulator is aminomethyl propanol. The preservative is prepared by compounding phenoxyethanol and ethylhexyl glycerin.
The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The raw materials, reagents or instruments used are not indicated by manufacturers, and all are conventional products which can be obtained commercially.
The preparation method of the soothing moisturizing cream of embodiments 1 to 5 comprises the following steps:
(1) stirring the phase A beta-glucan, the polyalcohol, the chelating agent, the thickening agent and the skin conditioning agent by using part of deionized water until the beta-glucan, the polyalcohol, the chelating agent, the thickening agent and the skin conditioning agent are completely dissolved, heating to 80-85 ℃, and keeping the temperature;
(2) stirring the ceramide III, the cetyl-PG hydroxyethyl palmitamide, the emulsifier, the emollient and the antioxidant of the phase B with the rest deionized water until the ceramide III, the cetyl-PG hydroxyethyl palmitamide, the emulsifier, the emollient and the antioxidant are completely dissolved, heating to 80-85 ℃, and keeping the temperature;
(3) adding the phase B into the phase A raw material, and homogenizing at constant temperature for 3-5 minutes;
(4) cooling to 45 deg.C under stirring, adding Scutellariae radix extract of phase C, pH regulator and antiseptic, and stirring;
(5) stirring and cooling to below 38 ℃, and filtering out impurities to obtain the finished product.
Specifically, the specific formulation compositions of the soothing and moisturizing creams of examples 1-5 are shown in table 1 below.
TABLE 1 formula of soothing moisturizer of examples 1-5
The effects of the present invention are verified by comparing comparative examples 1 to 10 with the present invention.
The creams are provided in comparative examples 1 to 10, and the specific formula composition of the creams in the comparative examples 1 to 10 is shown in the following table 2. The preparation method of the creams of comparative examples 1 to 10 is the same as that of example 1.
TABLE 2 formulation of creams of comparative examples 1 to 10
The soothing, moisturizing and repairing effects of examples 1 to 5 and comparative examples 1 to 10 are demonstrated by tests below.
1. Patch test on human skin
1.1 test substance: the soothing and moisturizing cream prepared in the embodiments 1-5 of the invention;
1.2 subjects: the age of 10 men and 22 women is 20-40 years, and the total of 32 men and women meet the volunteer enrollment standard of the subject;
1.3 test methods: placing the tested object in a proper spot sticking device by adopting a closed test method, sticking the tested object on the arm curve side of the tested object by using a hypoallergenic adhesive tape, and lightly pressing the tested object by using a palm to uniformly stick the tested object on the skin for 24 hours; the blank control group was subject without product;
1.4 observations: the test devices were removed after 24 hours, the skin reactions were observed after 0.5h, 24h, 48h, respectively, and the reaction results were recorded. The grade of the adverse reaction of the skin is shown in Table 3, and the test results are shown in Table 4.
TABLE 3 skin response grading Standard for skin Enclosed Patch test
TABLE 4 test results of human skin patches
The results in Table 4 show that in 32 subjects, the examples 1-5 have no adverse skin reactions, which indicates that the soothing and moisturizing creams of the examples 1-5 are safe and non-irritant.
2. Moisturizing test
The soothing moisturizing cream in the example 1 and the creams prepared in the comparative examples 1 to 10 are selected as test samples, and moisturizing effect evaluation is carried out on testers, wherein the specific experimental design is as follows:
and 5 effective subjects are selected for testing each sample, and the test is carried out under the same test condition, wherein the temperature is 20-22 ℃, and the humidity is 40-60%. Before the test, the subject was tested by the staff in the unified clean both hands forearm: the area marking was measured on the inner forearm of the subject, the area of the test area was 3cm x 3cm, and the same arm could mark multiple areas, each 2cm apart. Before formal test, the people need to sit in a room with constant temperature and humidity for half an hour. Carrying out an initial value (0h) test of the skin stratum corneum moisture; at 0.055mL sample/cm2The amount of the skin moisture content in the area is measured by using a skin moisture content measuring probe after the sample is smeared in the test area and is massaged until the sample is completely absorbed for 30 minutes, namely the skin moisture content in the 30-minute area. The stratum corneum moisture content was then tested at 60, 120, and 180 minutes after application, and the results are shown in table 5.
TABLE 5 skin cuticle water content test results
As can be seen from the data in table 5: compared with the cream before use, the soothing and moisturizing cream in the example 1 and the creams prepared in the comparative examples 1-10 improve the moisture content of the skin to a certain extent when used for 180 minutes, except for the comparative example 6, the test effect of the example 1 is more obvious, and the soothing and moisturizing cream prepared by compounding the beta-glucan, the scutellaria alpina flower/leaf/stem extract, the ceramide III and the cetyl-PG hydroxyethyl palmitoyl improves the moisture content of the skin and has better moisturizing and moisturizing effects.
Comparative example 6 and example 1 did not show much difference in test effect, but comparative example 6 greatly increased the amounts of β -glucan, scutellaria alpina flower/leaf/stem extract, ceramide iii and cetyl-PG hydroxyethyl palmitoyl in the formulation, increasing production costs.
3. Testing of repair effect
A skin damage model is established by SDS stimulation of a certain concentration, and after test samples are continuously smeared on damaged skin for 7 days, the repairing efficacy of the samples on the damaged skin caused by the SDS stimulation is evaluated through a skin erythrocin and percutaneous water loss TEWL test.
Test samples: 11 groups of soothing and moisturizing cream prepared in example 1 and cream prepared in comparative examples 1-10.
Testing the population: 5 persons/group, women 25-45 years old.
Testing an instrument: german CK company multifunctional tester, probe model Tewameter TM 300.
The test method comprises the following steps: the skin heme was measured in the test area using a skin heme tester (MX18, Courage and Khazaka, Germany) and a multifunctional tester (Probe model TewameterTM300) from CK corporation, Germany, 2 times a day for 7 consecutive days, before using the samples after the model was established (D0), after using the samples 1, 3, 5, 7 days (D1, D3, D5, D7). The larger the skin heme index EI value is, the higher the skin heme content is; the larger the mean value of skin TEWL, the faster the transdermal water loss of the skin. The test results are shown in tables 6 and 7 below.
TABLE 6 skin heme index EI values
TABLE 7 transdermal Water loss data
As can be seen from table 6, compared with the blank group, the soothing and moisturizing cream prepared in example 1 and the creams prepared in comparative examples 1 to 10 both have a certain effect of removing redness of skin caused by SDS stimulation, and except for comparative example 6, the effect of removing redness of the soothing and moisturizing cream prepared in example 1 is more remarkable, which indicates that the soothing and moisturizing cream prepared by compounding beta-glucan, scutellaria alpina flower/leaf/stem extract, ceramide iii and cetyl-PG hydroxyethyl palmitoyl can synergize, the effect of reducing heme EI value of the soothing and moisturizing cream is improved, and the soothing and moisturizing cream of the present invention has the effect of relieving SDS stimulation. While the test results of comparative example 6 and example 1 are not very different, comparative example 6 greatly increased the amounts of β -glucan, scutellaria alpina flower/leaf/stem extract, ceramide iii and cetyl-PG hydroxyethylpalmitoyl in the formulation, increasing the production cost.
As can be seen from Table 7, compared with the blank control group, the soothing and moisturizing cream prepared in example 1 and the creams prepared in comparative examples 1-10 have a certain effect on reducing the percutaneous water loss, but after the product of 7 days is used, the soothing and moisturizing cream prepared in example 1 has the most remarkable effect on reducing the percutaneous water loss except for the comparative example 6. The soothing and repairing cream prepared by compounding the beta-glucan, the scutellaria alpina flower/leaf/stem extract, the ceramide III and the cetyl-PG hydroxyethyl palmitoyl can realize synergistic interaction, the effect of the soothing and moisturizing cream on reducing the percutaneous water loss is improved, and the soothing and moisturizing cream prepared by the invention has the effect of repairing the skin barrier. Although the test effects of the comparative example 6 and the example 1 are not very different, the comparative example 6 greatly improves the dosage of the beta-glucan, the scutellaria alpina flower/leaf/stem extract, the ceramide III and the cetyl-PG hydroxyethyl palmitoyl in the formula, increases the production cost, is not in line with the actual production benefit, and also shows that the moisturizing and relieving composition can achieve a good effect of relieving, moisturizing and repairing the skin barrier within a certain concentration range, and the more the dosage is, the better the effect is.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and should not be taken as limiting the scope of the present invention, which is intended to cover any modifications, equivalents, improvements, etc. within the spirit and scope of the present invention.
Furthermore, it should be understood that although the present description refers to embodiments, not every embodiment may contain only a single embodiment, and such description is for clarity only, and those skilled in the art should integrate the description, and the embodiments may be combined as appropriate to form other embodiments understood by those skilled in the art.
Claims (10)
1. The soothing and moisturizing composition suitable for desert muscles is characterized by comprising the following raw materials in percentage by weight:
2. a soothing moisturizing composition as claimed in claim 1, characterized in that: the Scutellariae radix extract is flos Scutellariae Baicalensis flower/leaf/stem extract, and is obtained by extracting flos Scutellariae Baicalensis leaf and stem together.
3. A soothing moisturizing composition as claimed in claim 1, wherein: the soothing moisturizing composition further comprises a polyol, a chelating agent, a thickening agent, a skin conditioner, deionized water, an emulsifier, an emollient, an antioxidant, a pH regulator, and a preservative.
4. A soothing moisturizing composition as claimed in claim 3, wherein: the soothing and moisturizing composition is prepared from the following raw materials in percentage by weight:
phase A: beta-glucan 0.02-0.7%, polyhydric alcohol 2-10%, chelating agent 0.01-0.5%, thickening agent 0.01-5%, skin conditioner 0.01-5%, and deionized water to make up to 100%;
phase B: 0.1 to 0.5 percent of ceramide III, 1 to 7 percent of cetyl-PG hydroxyethyl palmitamide, 0.5 to 5 percent of emulsifier, 1 to 10.5 percent of emollient and 0.01 to 1 percent of antioxidant;
and C phase: 0.5 to 3 percent of scutellaria baicalensis extract, 0.01 to 2 percent of PH regulator and 0.01 to 2 percent of preservative.
5. A soothing moisturizing composition according to claim 4, characterized in that: the soothing and moisturizing composition is prepared from the following raw materials in percentage by weight:
phase A: beta-glucan 0.2%, polyhydric alcohol 2.5%, chelating agent 0.05%, thickening agent 0.4%, skin conditioner 0.17%, and deionized water to make up to 100%;
phase B: 0.5% of ceramide III, 5% of cetyl-PG hydroxyethyl palmitamide, 1.7% of emulsifier, 10.5% of emollient and 0.5% of antioxidant;
and C phase: 2.5 percent of scutellaria baicalensis extract, 0.2 percent of pH regulator and 0.55 percent of preservative.
6. A soothing moisturizing composition according to any of claims 3 to 5, characterized in that: the polyalcohol is at least one of glycerol, panthenol, propylene glycol, butanediol and hexanediol;
the chelating agent is EDTA disodium;
the preservative is at least one of phenoxyethanol, methyl hydroxybenzoate and ethylhexylglycerin;
the thickening agent is at least one of acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, carbomer, hydroxyethyl cellulose, hydroxyethyl acrylate, sodium acryloyldimethyl taurate copolymer and xanthan gum;
the emulsifier is at least one of cetearyl glucoside, methyl glucose sesquistearate, PEG-20 methyl glucose sesquistearate, cetearyl olive oleate, PEG-100 stearate, and glyceryl stearate.
7. A soothing moisturizing composition according to any of claims 3 to 5, characterized in that: the antioxidant is tocopherol acetate;
the emollient is at least one of isononyl isononanoate, caprylic capric triglyceride, hydrogenated polyisobutene, shea butter and dioctyl carbonate;
the skin conditioner is at least one of allantoin, sodium hyaluronate, hydrolyzed collagen, hydrolyzed sclerotium rolfsii gum, fucus extract and arginine/lysine polypeptide;
the pH regulator is at least one of triethanolamine, aminomethyl propanol, potassium hydroxide, sodium hydroxide, citric acid and sodium citrate.
8. A process for preparing a soothing moisturizing composition as claimed in any of claims 3 to 5, comprising the steps of:
(1) stirring the phase A beta-glucan, the polyalcohol, the chelating agent, the thickening agent and the skin conditioning agent by using part of deionized water until the beta-glucan, the polyalcohol, the chelating agent, the thickening agent and the skin conditioning agent are completely dissolved, heating to 80-85 ℃, and keeping the temperature;
(2) stirring the ceramide III, the cetyl-PG hydroxyethyl palmitamide, the emulsifier, the emollient and the antioxidant of the phase B by using the rest deionized water until the ceramide III, the cetyl-PG hydroxyethyl palmitamide, the emulsifier, the emollient and the antioxidant are completely dissolved, heating to 80-85 ℃, and preserving heat;
(3) adding the phase B into the phase A raw material, and homogenizing at constant temperature for 3-5 minutes;
(4) cooling to 45 deg.C under stirring, adding Scutellariae radix extract of phase C, pH regulator and antiseptic, and stirring;
(5) stirring and cooling to below 38 ℃, and filtering out impurities to obtain the finished product.
9. Use of a soothing moisturizing composition as defined in any one of claims 1 to 5 in a cosmetic for desert skin.
10. Use according to claim 9, characterized in that: the cosmetic is any one of soothing moisturizing lotion, soothing moisturizing cream and soothing moisturizing cream.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210600680.5A CN114748396A (en) | 2022-05-30 | 2022-05-30 | Soothing and moisturizing composition suitable for desert muscles and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210600680.5A CN114748396A (en) | 2022-05-30 | 2022-05-30 | Soothing and moisturizing composition suitable for desert muscles and preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114748396A true CN114748396A (en) | 2022-07-15 |
Family
ID=82336188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210600680.5A Pending CN114748396A (en) | 2022-05-30 | 2022-05-30 | Soothing and moisturizing composition suitable for desert muscles and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114748396A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115429730A (en) * | 2022-10-09 | 2022-12-06 | 伯德创研(广州)生物科技有限公司 | Moisturizing repair cream and preparation method thereof |
| CN116077375A (en) * | 2023-01-03 | 2023-05-09 | 广州睿森生物科技有限公司 | Multiple chitosan soothing composition and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111150681A (en) * | 2020-02-26 | 2020-05-15 | 广州留今科学研究有限公司 | Moisturizing compound containing symbiotic bacteria combined fermentation product, moisturizing essence and preparation method of moisturizing compound |
| CN111265442A (en) * | 2020-03-18 | 2020-06-12 | 上海科颜生物科技有限公司 | Skin care composition and application thereof |
| CN114028260A (en) * | 2021-11-09 | 2022-02-11 | 上海药坦药物研究开发有限公司 | Ceramide E emulsifier, preparation method thereof and application thereof in cosmetics |
| CN114533585A (en) * | 2022-02-26 | 2022-05-27 | 宝钡新材料有限公司 | Barium sulfate-containing skin care product capable of blocking ultraviolet radiation |
-
2022
- 2022-05-30 CN CN202210600680.5A patent/CN114748396A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111150681A (en) * | 2020-02-26 | 2020-05-15 | 广州留今科学研究有限公司 | Moisturizing compound containing symbiotic bacteria combined fermentation product, moisturizing essence and preparation method of moisturizing compound |
| CN111265442A (en) * | 2020-03-18 | 2020-06-12 | 上海科颜生物科技有限公司 | Skin care composition and application thereof |
| CN114028260A (en) * | 2021-11-09 | 2022-02-11 | 上海药坦药物研究开发有限公司 | Ceramide E emulsifier, preparation method thereof and application thereof in cosmetics |
| CN114533585A (en) * | 2022-02-26 | 2022-05-27 | 宝钡新材料有限公司 | Barium sulfate-containing skin care product capable of blocking ultraviolet radiation |
Non-Patent Citations (1)
| Title |
|---|
| 广州芬臣生物科技有限公司: "enne神经酰胺精华液", 《HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=202104261816053OCQ8&NID=202104261816053OCQ8》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115429730A (en) * | 2022-10-09 | 2022-12-06 | 伯德创研(广州)生物科技有限公司 | Moisturizing repair cream and preparation method thereof |
| CN116077375A (en) * | 2023-01-03 | 2023-05-09 | 广州睿森生物科技有限公司 | Multiple chitosan soothing composition and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111557874B (en) | Bionic skin barrier repairing composition containing camellia extract and application | |
| CN114748396A (en) | Soothing and moisturizing composition suitable for desert muscles and preparation method and application thereof | |
| CN110585048B (en) | Composition with anti-saccharification and anti-oxidation functions and application thereof | |
| CN111529444A (en) | Composition with skin barrier repair function and preparation method and application thereof | |
| CN105769666A (en) | Composition and skin care product containing same | |
| CN111557886B (en) | Plant-nourishing efficient moisturizing cream and preparation method thereof | |
| CN111920746B (en) | Moisturizing and repairing mask and preparation method thereof | |
| CN113398016A (en) | Skin soothing and repairing composition and cosmetic composition | |
| CN111973508A (en) | Anti-aging composition capable of relieving and moisturizing | |
| CN114224779A (en) | Eye repair composition and application thereof | |
| CN111920730A (en) | Repairing moisturizing cream and preparation method thereof | |
| CN110946784A (en) | Skin care composition with functions of improving skin barrier function and enhancing skin health | |
| CN113952258A (en) | Plant extract moisturizing essential oil special for pregnancy and preparation process thereof | |
| CN110037976B (en) | Moisturizing and anti-inflammatory composition and skin care product | |
| CN115517999A (en) | Anti-aging composition and application thereof in beauty and skin care | |
| CN115919722A (en) | Pandanus communis leaf extract and preparation method and application thereof | |
| CN112773761B (en) | Cosmetic composition, essence and preparation method thereof | |
| CN114272184A (en) | Polypeptide composition, anti-aging repair eye cream containing polypeptide composition and preparation method of anti-aging repair eye cream | |
| CN116139060B (en) | Composition with anti-inflammatory and anti-aging effects and preparation method and application thereof | |
| CN115778870A (en) | Anti-wrinkle anti-aging composition and preparation method and application thereof | |
| CN112933018B (en) | Composition with barrier repairing and anti-photoaging effects and preparation method and application thereof | |
| CN109846796A (en) | A kind of skin cream of the oil containing Seeds of Camellia sinensis var. assamica | |
| CN114344211A (en) | Moisturizing and stabilizing composition and preparation method thereof | |
| CN111419732A (en) | Protective composition and application thereof in indoor protective cosmetics | |
| CN112274459A (en) | Moisture mask and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220715 |
|
| RJ01 | Rejection of invention patent application after publication |